Why the study?
The clinical profile of patients with obstructive hypertrophic cardiomyopathy was not well characterized, with little evidence outside selected referral populations.
Cohort (n=1,841)
Yes
In a real-world US community-based population, patients newly diagnosed with obstructive hypertrophic cardiomyopathy are older and have a higher comorbidity burden than those in referral centers, with low rates of guideline-supported surgical procedures.
Low utilization of ICDs and septal reduction in community obstructive HCM warrants caution extrapolating referral-center data; leaves open reasons for observed disparity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Butzner et al. (2022) conducted a cohort in obstructive hypertrophic cardiomyopathy (n=1,841). Community-based cardiovascular practice care was evaluated on Clinical characteristics, medication use, and surgical procedures at 2-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: